Isolation and expression of the Pneumocystis carinii dihydrofolate reductase gene.
AUTOR(ES)
Edman, J C
RESUMO
Pneumocystis carinii dihydrofolate reductase (DHFR; 5,6,7,8-tetrahydrofolate: NADP+ oxidoreductase, EC 1.5.1.3) cDNA sequences have been isolated by their ability to confer trimethoprim resistance to Escherichia coli. Consistent with the recent conclusion that P. carinii is a member of the Fungi, sequence analysis and chromosomal localization show that DHFR is neither physically nor genetically linked to thymidylate synthase. Expression of recombinant P. carinii DHFR in heterologous hosts provides an abundant source of the enzyme that may form a basis for the development of new therapies for this enigmatic pathogen. Studies with the recombinant enzyme show that trimethoprim is a very poor inhibitor of P. carinii DHFR and, in fact, is a more potent inhibitor of human DHFR.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=298340Documentos Relacionados
- Isolation and expression of the Pneumocystis carinii thymidylate synthase gene.
- Expression and Characterization of Recombinant Human-Derived Pneumocystis carinii Dihydrofolate Reductase
- Pneumocystis carinii dihydrofolate reductase used to screen potential antipneumocystis drugs.
- 6,7-disubstituted 2,4-diaminopteridines: novel inhibitors of Pneumocystis carinii and Toxoplasma gondii dihydrofolate reductase.
- Evaluation of potent inhibitors of dihydrofolate reductase in a culture model for growth of Pneumocystis carinii.